Management of Oral Mucositis in Children With Malignant Solid Tumors

Abstract

IntroductionIn recent years, the use of intensive regimens for the treatment of pediatric cancer has led to a marked improvement in patient survival. However, these treatments are associated with an increase in toxic effects. Among these side effects, mucositis (inflammation of the oral cavity) significantly affect the success of treatment. The aim of this study was to assess the prevalence of mucositis in a pediatric population with solid tumor and undergoing chemotherapy, identify the risk factors that influence its occurrence, and verify the usefulness of pain rating scales.MethodsWe registered episodes of mucositis which occurred in a sample of 84 consecutive children with solid tumors between 1 January, 2012 and 30 April, 2018. The World Health Organization (WHO) oral mucositis grading scale and the modified Wong–Baker FACES Pain Rating Scale (WBS) were used to assess the severity of each episode. Moreover, data on the treatments used and blood count results were collected.ResultsThe prevalence of mucositis in our population was 50%, without statistically significant difference according to sex and a higher prevalence observed in patients aged >10 years. The presence of neutropenia, higher number of cycles of chemotherapy, and co-existence of lymphomas and sarcomas were identified as factors favoring the occurrence of mucositis. The WBS showed results superimposed on the WHO oral mucositis grading scale in choosing the intensity and duration of mucositis treatment.ConclusionOral mucositis is a common complication of chemotherapy against childhood malignancies. The WHO oral mucositis scale is a valuable tool for assessing its severity in pediatric patients. Furthermore, WBS can be used as an assessment tool to establish the therapy to be adopted for patients in whom direct evaluation of the oral cavity is not possible.

Photobiomodulation for chemotherapy‐induced oral mucositis in leukemic children: A randomized controlled clinical trial

“…Numerous studies have addressed the treatment of OM, including multi‐disciplinary oral care protocols, the use of mouthwashes, glutamine, morphine, and several anti‐oxidizing agents (Qutob et al, 2013; Ribeiro da Silva et al, 2018). However, there has been no agreement about the level of evidence presented by these studies or the best therapeutic choice (Attinà et al, 2021).…”

Effectiveness of Application of Oral Regimen, Practicing Oral Health, Health Education, Observation (APHO) Nursing Intervention in Preventing and Managing Oral Mucositis in Children Undergoing Chemotherapy: An Interventional Study in Central India

“…The use of intensive regimens in treating paediatric cancer has led to a significant increase in patient survival in recent years. However, these treatments are also associated with a rise in harmful effects, including mucositis (oral cavity inflammation), which can have a substantial impact on treatment efficacy [ 1 ].…”

Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors

“…In recent years, the improvement in childhood cancer treatments and the adoption of international cooperative treatment regimens, which permit the combination of surgery, radiotherapy and chemotherapy, resulted in a marked increase in survival [ 1 , 2 ]. In parallel with the increase in survival, increased toxicity was observed, and treatment-related long-term side effects were noted [ 3 , 4 ]. Chemotherapy, high-dose steroid therapy and radiotherapy cause long-term toxic effects on numerous organs, including the kidneys, heart, endocrine system, and ear [ 5 , 6 , 7 ].…”